NF, R., TR, P., YM, K., K, M., G, D., C, N., & PC, J. (2022). Chlorhexidine gluconate vs povidone-iodine vaginal antisepsis for urogynecologic surgery: A randomized controlled noninferiority trial. American journal of obstetrics and gynecology, 227(1), 66.e1-66.e9. https://doi.org/10.1016/j.ajog.2021.12.260
Chicago Style (17th ed.) CitationNF, Rockefeller, Petersen TR, Komesu YM, Meriwether K, Dunivan G, Ninivaggio C, and Jeppson PC. "Chlorhexidine Gluconate Vs Povidone-iodine Vaginal Antisepsis for Urogynecologic Surgery: A Randomized Controlled Noninferiority Trial." American Journal of Obstetrics and Gynecology 227, no. 1 (2022): 66.e1-66.e9. https://doi.org/10.1016/j.ajog.2021.12.260.
MLA (9th ed.) CitationNF, Rockefeller, et al. "Chlorhexidine Gluconate Vs Povidone-iodine Vaginal Antisepsis for Urogynecologic Surgery: A Randomized Controlled Noninferiority Trial." American Journal of Obstetrics and Gynecology, vol. 227, no. 1, 2022, pp. 66.e1-66.e9, https://doi.org/10.1016/j.ajog.2021.12.260.